Evidence map›Paper›PMID 28923849›Full record

ReviewMolecular and cellular biology2017

Bivalent Epigenetic Control of Oncofetal Gene Expression in Cancer.

Sayyed K Zaidi, Seth E Frietze, Jonathan A Gordon, Jessica L Heath, Terri Messier, Deli Hong, Joseph R Boyd, Mingu Kang, Anthony N Imbalzano, Jane B Lian and 2 more

Abstract readReview
In one paragraph

Review in Molecular and cellular biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Ion Transporting Proteins and Cancer: Progress and Perspectives.Reviews of physiology, biochemistry and pharmacology · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Bivalent Genes Targeting of Glioma Heterogeneity and Plasticity.International journal of molecular sciences · 2021
    Review
  16. Review
  17. Transcriptome and epigenome analyses of vernalization in Arabidopsis thaliana.The Plant journal : for cell and molecular biology · 2020
    Article
  18. Article
  19. Review
  20. AGenome research · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sayyed K ZaidiDepartment of Biochemistry, University of Vermont, Burlington, Vermont, USA.
Seth E FrietzeDepartment of Medical Laboratory and Radiation Sciences, University of Vermont, Burlington, Vermont, USA.ORCID http://orcid.org/0000-0003-4058-3661
Jonathan A GordonDepartment of Biochemistry, University of Vermont, Burlington, Vermont, USA.
Jessica L HeathDepartment of Biochemistry, University of Vermont, Burlington, Vermont, USA.
Terri MessierDepartment of Biochemistry, University of Vermont, Burlington, Vermont, USA.
Deli HongDepartment of Biochemistry, University of Vermont, Burlington, Vermont, USA.
Joseph R BoydDepartment of Biochemistry, University of Vermont, Burlington, Vermont, USA.
Mingu KangDepartment of Biochemistry, University of Vermont, Burlington, Vermont, USA.
Anthony N ImbalzanoDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Jane B LianDepartment of Biochemistry, University of Vermont, Burlington, Vermont, USA.
Janet L SteinDepartment of Biochemistry, University of Vermont, Burlington, Vermont, USA.
Gary S SteinDepartment of Biochemistry, University of Vermont, Burlington, Vermont, USA gary.stein@med.uvm.edu.

Funding

SUBNUCLEAR TARGETING OF TRANSCRIPTION FACTORSP01CA082834 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STEIN, GARY S. · 2001 to 2015
$18.4M
Systems Analysis of Epigenomic Architecture in Cancer ProgressionU54CA217297 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI HUANG, TIM H.-M. · 2017 to 2021
$9.3M
Vermont Breast Cancer Molecular Characterization LaboratoryU01CA196383 · NCI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI SPRAGUE, BRIAN L, STEIN, JANET L · 2015 to 2020
$5.4M
NCI NIH HHS P01 CA082834NCI NIH HHS U01 CA196383NCI NIH HHS U54 CA217297
6 · The paper itself

Abstract

Multiple mechanisms of epigenetic control that include DNA methylation, histone modification, noncoding RNAs, and mitotic gene bookmarking play pivotal roles in stringent gene regulation during lineage commitment and maintenance. Experimental evidence indicates that bivalent chromatin domains, i.e., genome regions that are marked by both H3K4me3 (activating) and H3K27me3 (repressive) histone modifications, are a key property of pluripotent stem cells. Bivalency of developmental genes during the G

Indexed as

AnimalsCell DifferentiationChromatinDNA MethylationGene Expression Regulation, DevelopmentalGene Expression Regulation, NeoplasticHistonesHumansChromatinHistonesbivalencycancerepigenetic controlnuclear structureoncofetal gene expression

Identifiers

PMID28923849
PMCPMC5686582

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.